Table 3 |
|||||||
|
Influence of positive end-expiratory pressure on respiratory and haemodynamic data at 26 mmHg intra-abdominal pressure |
|||||||
|
PEEP, cmH2O |
5 |
8 |
5 vs 8 |
12 |
5 vs 12 |
15 |
5 vs 15 |
|
|
|||||||
|
FRC, L |
1.0 (0.2) * |
1.0 (0.3) * |
NS |
1.0 (0.3) * |
NS |
1.0 (0.2) * |
NS |
|
PaO2, mmHg |
213 (24) |
215 (21) * |
NS |
212 (21) * |
NS |
212 (23) |
NS |
|
pPaw, cmH2O |
33 (4) * |
36 (4) * |
< 0.001 |
38 (5) * |
< 0.001 |
42 (4) * |
< 0.001 |
|
mPaw, cmH2O |
13 (4) * |
16 (4) * |
< 0.001 |
19 (4) * |
< 0.001 |
22 (4) * |
< 0.001 |
|
C dyn, ml/cmH2O |
13 (3) * |
13 (3) * |
NS |
13 (4) * |
NS |
12 (3) * |
NS |
|
CO, L/min |
3.2 (1.0) |
2.6 (0.6) * |
< 0.001 |
2.7 (0.9) |
< 0.001 |
2.5 (0.8) |
< 0.001 |
|
DO2, ml/min |
449 (161) |
367 (93) * |
0.035 |
377 (140) |
0.029 |
349 (124) |
0.005 |
|
SvO2, % |
58 (9) |
54 (14) |
0.007 |
53 (15) * |
0.02 |
52 (13) |
0.045 |
|
VO2, ml/min |
188 (38) |
179 (42) |
NS |
183 (54) |
NS |
165 (32) |
NS |
|
MAP, mmHg |
78 (13) |
74 (18) |
NS |
74 (15) * |
NS |
76 (17) * |
NS |
|
APP, mmHg |
52 (14) * |
48 (15) * |
NS |
48 (15) |
NS |
49 (17) |
NS |
|
CVP, mmHg |
11 (3) * |
12 (2) * |
NS |
13 (2) * |
0.012 |
17 (3) * |
< 0.001 |
|
PAOP, mmHg |
9 (2) |
11 (4) * |
0.024 |
12 (2) * |
0.007 |
14 (3) * |
< 0.001 |
|
HR, beats/min |
72 (10) |
78 (14) |
NS |
76 (13) |
NS |
80 (16) |
NS |
|
SVR, dyn * s/cm5 |
1,771 (446) |
1813 (404) * |
NS |
1,861 (490) * |
NS |
1,891 (419) * |
NS |
|
SV, ml |
44 (12) |
37 (14) * |
0.024 |
39 (18) |
0.037 |
33 (12) |
0.002 |
|
|
|||||||
|
APP, abdominal perfusion pressure; Cdyn, dynamic compliance; CO, cardiac output; CVP, central venous pressure; DO2, oxygen delivery; FRC, functional residual capacity; HR, heart rate; MAP, mean arterial pressure; mPaw, mean airway pressure; PaO2, arterial oxygen tension; PAOP, pulmonary artery occlusion pressure; PEEP, positive end-expiratory pressure; pPaw, peak airway pressure; SV, stroke volume; SvO2, mixed venous oxygen saturation; SVR, systemic vascular resistance; VO2, oxygen consumption. Mean (SD) are given. ANOVA and post hoc Student-Newman-Keuls were used for statistical testing. *, significant (P < 0.05) difference compared with baseline IAP. NS, not significant. |
|||||||
|
Regli et al. Critical Care 2010 14:R128 doi:10.1186/cc9095 |
|||||||